Dianthus Therapeutics (DNTH) Stock Insights

DNTH price $80.25 +0.73 +0.92%

Ticker
DNTH
Price
$80.25
Change
+0.73 +0.92%
Market cap ?
$4.49B
P/E ?
-605.77
Forward P/E ?
27.93
Dividend yield ?
0.00%
Beta ?
0.08
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
45
Value
57
Quality
29
Growth
50

Stocklytics score rationale: value 57, quality 29, growth 50.

Financials

2016201720182019202020212022202320242025
0000014760006417000282600062350002036000

Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid…

Fair value

DNTH fair value $49.30. Price $80.25. Price is 63% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 257.76K. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 55.93M. Net debt -49.70M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare DNTH

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.94—460.93K
2026-08-04-0.90-0.85761.00K297.18K
2026-05-05-0.85-1.17463.00K403.62K
2026-03-09-1.43-0.98284.00K552.23K
2025-11-05-0.97-0.86396.00K576.00K
2025-08-07-0.88-0.86193.00K858.20K
2025-05-12-0.82-0.861.16M806.90K
2025-03-11-0.81-0.851.32M955.22K
2024-11-07-0.74-0.592.17M741.14K
2024-08-08-0.51-0.551.86M368.86K
2024-05-09-0.54-0.43874.00K464.25K
2024-03-21-0.71-1.11457.00K548.50K
2023-11-09-3.78-0.51924.00K250.00K
2023-08-03-3.12-0.801.00M—
2023-05-15-7.52-6.40476.00K—
2022-11-03-4.32-4.641.17M—
2022-08-04-4.64-5.44——
2022-05-16-6.24-5.09——
2022-03-08-5.25———
2021-11-04-4.76———
2021-08-05-5.04———
2021-05-06-5.76———
2021-03-03-5.99———
2020-11-05-5.86———
2020-08-06-7.71———
2020-05-07-8.13———
2020-03-03-9.52———
2019-11-13-8.65———
2019-08-08-7.73———
2019-05-09-7.10———
2019-03-19-8.04———
2018-11-08-7.77———
2018-08-09-6.39———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-17CARR EDWARDSell20.00K$17.88357.60K
2026-09-17CARR EDWARDBuy20.00K$17.88357.60K
2026-09-17CARR EDWARDSell7.93K$100.43796.21K
2026-09-17CARR EDWARDSell6.77K$101.37686.38K
2026-09-17CARR EDWARDSell3.50K$102.39358.47K
2026-09-17CARR EDWARDSell1.10K$103.20113.52K
2026-09-17CARR EDWARDSell700$104.3973.07K
2026-09-01Randhawa SimratSell9.38K$22.07206.91K
2026-09-01Randhawa SimratSell7.50K$17.88134.10K
2026-09-01Randhawa SimratSell6.25K$21.77136.04K
2026-09-01Randhawa SimratBuy9.38K$22.07206.91K
2026-09-01Randhawa SimratSell2.60K$105.19273.49K
2026-09-01Randhawa SimratBuy6.25K$21.77136.04K
2026-09-01Randhawa SimratSell7.21K$106.25766.59K
2026-09-01Randhawa SimratBuy7.50K$17.88134.10K
2026-09-01Randhawa SimratSell13.31K$106.741.42M
2026-08-19Read SimonSell2.78K$18.3651.00K
2026-08-19Read SimonBuy2.78K$18.3651.00K
2026-08-19Read SimonSell2.78K$117.55326.55K
2026-08-13Veness Adam MSell15.00K$18.17272.55K
2026-08-13Veness Adam MBuy15.00K$18.17272.55K
2026-08-10McGeorge AnneBuy6.50K$11.2072.80K
2026-08-10McGeorge AnneSell1.45K$107.58155.99K
2026-08-10McGeorge AnneSell2.80K$108.38303.46K
2026-08-10McGeorge AnneSell1.80K$109.30196.74K
2026-08-10McGeorge AnneBuy1.25K$19.3624.20K
2026-08-10McGeorge AnneSell1.00K$110.64110.64K
2026-08-10McGeorge AnneSell6.50K$11.2072.80K
2026-08-10McGeorge AnneSell700$111.4177.99K
2026-08-10McGeorge AnneSell1.25K$19.3624.20K
2026-08-10Read SimonSell2.78K$18.3650.99K
2026-08-10Read SimonBuy2.78K$18.3650.99K
2026-08-10Read SimonSell70$107.117.50K
2026-08-10Read SimonSell737$108.1779.72K
2026-08-10Read SimonSell831$108.9590.54K
2026-08-10Read SimonSell272$109.9629.91K
2026-08-10Read SimonSell470$111.0552.19K
2026-08-10Read SimonSell397$111.7744.37K
2026-08-10Veness Adam MSell16.17K$17.88289.07K
2026-08-10Veness Adam MBuy16.17K$17.88289.07K
2026-08-10Veness Adam MSell16.17K$110.381.78M
2026-08-07Veness Adam MSell3.83K$17.8868.53K
2026-08-07Veness Adam MBuy3.83K$17.8868.53K
2026-08-07Veness Adam MSell3.22K$110.61355.83K
2026-08-07Veness Adam MSell616$111.1868.49K
2026-08-07Garcia MarinoSell40.00K$8.44337.60K
2026-08-07Garcia MarinoBuy126.00K$8.441.06M
2026-08-07Garcia MarinoSell10.38K$107.491.12M
2026-08-07Garcia MarinoSell23.91K$108.052.58M
2026-08-07Garcia MarinoSell2.37K$109.10258.89K
2026-08-07Garcia MarinoSell2.54K$110.02279.01K
2026-08-07Garcia MarinoSell800$110.7688.61K
2026-08-07Garcia MarinoSell126.00K$8.441.06M
2026-08-07Garcia MarinoBuy40.00K$8.44337.60K
2026-08-07Garcia MarinoSell104.09K$107.9611.24M
2026-08-07Garcia MarinoSell21.91K$108.722.38M
2026-07-09Savitz RyanSell31.25K$21.77680.29K
2026-07-09Savitz RyanBuy31.25K$21.77680.29K
2026-07-09Savitz RyanSell10.35K$100.221.04M
2026-07-09Savitz RyanSell15.33K$101.241.55M
2026-07-09Savitz RyanSell5.57K$101.97567.57K
2026-06-17Veness Adam MSell30.00K$17.88536.40K
2026-06-17Veness Adam MBuy30.00K$17.88536.40K
2026-06-17Veness Adam MSell16.77K$80.341.35M
2026-06-17Veness Adam MSell13.23K$81.381.08M
2026-06-01Randhawa SimratSell9.38K$22.07206.91K
2026-06-01Randhawa SimratSell6.91K$17.88123.52K
2026-06-01Randhawa SimratSell6.25K$21.77136.04K
2026-06-01Randhawa SimratBuy9.38K$22.07206.91K
2026-06-01Randhawa SimratSell5.43K$89.72487.00K
2026-06-01Randhawa SimratBuy6.25K$21.77136.04K
2026-06-01Randhawa SimratBuy6.91K$17.88123.52K
2026-06-01Randhawa SimratSell16.94K$90.721.54M
2026-06-01Randhawa SimratBuy4.00K$8.4433.74K
2026-06-01Randhawa SimratSell4.16K$91.37380.01K
2026-06-01Randhawa SimratSell4.00K$8.4433.74K
2026-05-21Romano Steven J.Buy6.09K$89.63545.85K
2026-05-21Read SimonBuy6.09K$89.63545.85K
2026-05-21Lawton Alison FrancesBuy6.09K$89.63545.85K
2026-05-21McGeorge AnneBuy6.09K$89.63545.85K
2026-05-21KANGO SUJAYBuy6.09K$89.63545.85K
2026-05-21Violin JonathanBuy6.09K$89.63545.85K
2026-05-21Soteropoulos PaulaBuy6.09K$89.63545.85K
2026-05-08Soteropoulos PaulaBuy599$8.445.06K
2026-05-08Soteropoulos PaulaSell599$85.4751.20K
2026-05-08Soteropoulos PaulaSell599$8.445.06K
2026-04-09Savitz RyanSell8.22K$17.88147.05K
2026-04-09Savitz RyanBuy8.22K$17.88147.05K
2026-04-09Savitz RyanSell8.22K$89.84738.84K
2026-03-31Savitz RyanBuy40.00K$17.88715.20K
2026-03-31Savitz RyanSell1.39K$78.33108.88K
2026-03-31Savitz RyanSell21.82K$78.861.72M
2026-03-31Savitz RyanSell1.49K$80.25119.17K
2026-03-31Savitz RyanSell800$81.3665.09K
2026-03-31Savitz RyanSell2.37K$82.84196.00K
2026-03-31Savitz RyanSell40.00K$17.88715.20K
2026-03-31Savitz RyanBuy74.37K$8.44627.66K
2026-03-31Savitz RyanSell59.80K$83.905.02M
2026-03-31Savitz RyanSell74.37K$8.44627.66K
2026-03-31Savitz RyanSell19.47K$84.571.65M

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 279, holders +29 vs prior quarter. Ownership 137.66%.

HolderSharesChangeChange %Value
FMR LLC8.20M432.21K+5.56%799.33M
BLACKROCK, INC.4.12M948.12K+29.86%401.99M
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.3.89M2.60M+200.92%379.05M
WELLINGTON MANAGEMENT GROUP LLP3.23M634.10K+24.43%314.85M
FAIRMOUNT FUNDS MANAGEMENT LLC2.54M00.00%247.33M
PRICE T ROWE ASSOCIATES INC /MD/2.51M1.37M+119.27%245.16M
STATE STREET CORP2.36M958.53K+68.52%229.80M
VANGUARD CAPITAL MANAGEMENT LLC2.16M128.32K+6.32%210.51M
AVIDITY PARTNERS MANAGEMENT LP2.10M00.00%205.12M
OCTAGON CAPITAL ADVISORS LP1.84M-105.00K-5.39%179.53M
TCG CROSSOVER MANAGEMENT, LLC1.68M00.00%163.44M
FRED ALGER MANAGEMENT, LLC1.30M140.57K+12.10%126.97M
GEODE CAPITAL MANAGEMENT, LLC1.26M342.29K+37.36%122.70M
VENROCK ADVISER, LLC1.18M00.00%115.03M
UBS GROUP AG1.14M358.98K+45.95%111.15M
DEERFIELD MANAGEMENT COMPANY, L.P.1.13M105.50K+10.35%109.70M
JENNISON ASSOCIATES LLC1.02M536.63K+110.61%99.60M
POLAR CAPITAL HOLDINGS PLC1.02M-57.28K-5.32%99.31M
CITADEL ADVISORS LLC974.91K-635.57K-39.46%95.03M
FRANKLIN TEMPLETON INC968.98K801+0.08%94.46M
BAKER BROS. ADVISORS LP852.16K00.00%83.07M
LOGOS GLOBAL MANAGEMENT LP800.00K400.00K+100.00%77.98M
CORMORANT ASSET MANAGEMENT, LP750.00K-200.00K-21.05%73.11M
ALLIANCEBERNSTEIN L.P.834.15K-91.92K-9.93%70.00M
BRAIDWELL LP594.56K-304.80K-33.89%57.96M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Dianthus Therapeutics (DNTH) Stock Insights

DNTH$80.25+0.73 +0.92%

$4.49B

Market Cap

-605.77

P/E

27.93

Forward P/E

45

Score

Price History